Flatirons Pharmaceutical LLC Longmont, CO - 80503

Flatirons Pharmaceutical LLC is categorized under Wholesale Pharmaceutical Products in Longmont, CO and active since 2012.

Flatirons Pharmaceutical LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact James Carron at the company’s single location by writing to 4119 Riley Drive, Longmont, Colorado CO 80503 or by phoning (303) 827-3304. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Flatirons Pharmaceutical LLC
Contact Person: James Carron
Address: 4119 Riley Drive, Longmont, Colorado 80503
Phone Number: (303) 827-3304
Annual Revenue (USD): $50.000 to $99.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Flatirons Pharmaceutical LLC was started in 2012 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact James Carron for inquiries that concern Flatirons Pharmaceutical LLC by calling the company number (303) 827-3304, as your correspondence is most welcome. Additionally, the physical location of the single location of Flatirons Pharmaceutical LLC can be found at the coordinates 40.137374,-105.157729 as well as the street address 4119 Riley Drive in Longmont, Colorado 80503.

For its online presence, you may visit Flatirons Pharmaceutical LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.